Article
Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma
2022-02-02
Abstract excerpt
<title>Abstract</title> <p>Hepatocellular carcinoma (HCC) remains an incurable malignancy despite the treatment methods being continually updated. Matrix metalloproteinases (MMPs) promote the progression of HCC; however, no consensus exists on which MMP plays the predominant role in HCCs. In the present study, we analyzed differentially expressed genes in HCCs, especially MMPs, compared with adjacent tissues usin...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 55591136-ec15-57b8-adb3-3336551ccd17
- DOI
- 10.21203/rs.3.rs-1265614/v1
